Congress did not take any action this spring to regulate the operations of pharmacy benefit managers (PBMs), which is exactly what the lobbyists for the industry wanted. The Pharmaceutical Care Management Association, the largest trade group representing PBMs, increased its spending on lobbying by 71% in the first three months of this year compared to 2023, spending $4.8 million.
During negotiations, the odds were against PBMs, who are the middlemen between drugmakers and health insurers. The House passed a package aimed at increasing transparency, while two Senate committees passed significant reforms to how PBMs operate in Medicaid, Medicare, and the commercial insurance market. Public health programs, which are usually noncontroversial, had to be funded in a large government spending bill, allowing members of Congress to avoid voting on individual issues.
A celebration planned for a nonprofit providing mental health care to LGBTQIA+ clients in the…
In a historic match, Ukrainian fighter Oleksandr Usyk defeated UK's Tyson Fury in a razor-thin…
Iran’s official news agency, IRNA reported that the police in Shahrir, southwest of Tehran, conducted…
The release of the new Android update comes at a time when smartphone theft is…
Celtics big man Kristaps Porzingis will miss at least the first two games of the…
The majority of infection cases in adults are attributed to sexual contact, particularly between men.…